{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:57:16Z","timestamp":1776261436571,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":772,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","journals.elsevierhealth.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ajpath.2017.07.014","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T05:47:21Z","timestamp":1503035241000},"page":"2378-2387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Magnetic Resonance Imaging and Molecular Characterization of a Hormone-Mediated Murine Model of Prostate Enlargement and Bladder Outlet Obstruction"],"prefix":"10.1016","volume":"187","author":[{"given":"Erin M.","family":"McAuley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devkumar","family":"Mustafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian W.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Valek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Markiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Lamperis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian B.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7058-5399","authenticated-orcid":false,"given":"Chad","family":"Vezina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Karczmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aytekin","family":"Oto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald J.","family":"Vander Griend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2017.07.014_bib1","series-title":"Control of Cell Proliferation and Cell Death in the Normal and Neoplastic Prostate: A Stem Cell Model","author":"Isaacs","year":"1987"},{"key":"10.1016\/j.ajpath.2017.07.014_bib2","first-page":"340","article-title":"Origin and evolution of benign prostatic enlargement","volume":"15","author":"McNeal","year":"1978","journal-title":"Invest Urol"},{"key":"10.1016\/j.ajpath.2017.07.014_bib3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.4155\/cli.14.77","article-title":"Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer","volume":"4","author":"Izumi","year":"2014","journal-title":"Clin Invest"},{"issue":"Suppl 5","key":"10.1016\/j.ajpath.2017.07.014_bib4","first-page":"S3","article-title":"Clinical evaluation of benign prostatic hyperplasia","volume":"5","author":"McVary","year":"2003","journal-title":"Rev Urol"},{"key":"10.1016\/j.ajpath.2017.07.014_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/pros.2990020105","article-title":"The zonal anatomy of the prostate","volume":"2","author":"McNeal","year":"1981","journal-title":"Prostate"},{"key":"10.1016\/j.ajpath.2017.07.014_bib6","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/pros.20763","article-title":"Prostate stem cells and benign prostatic hyperplasia","volume":"68","author":"Isaacs","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.ajpath.2017.07.014_bib7","doi-asserted-by":"crossref","first-page":"107954","DOI":"10.1155\/2013\/107954","article-title":"Prostate stem cells in the development of benign prostate hyperplasia and prostate cancer: emerging role and concepts","volume":"2013","author":"Prajapati","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ajpath.2017.07.014_bib8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10565-012-9234-x","article-title":"Benign prostate hyperplasia and stem cells: a new therapeutic opportunity","volume":"28","author":"Notara","year":"2012","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.ajpath.2017.07.014_bib9","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1172\/JCI109532","article-title":"Comparison of spontaneous and experimentally induced canine prostatic hyperplasia","volume":"64","author":"DeKlerk","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2017.07.014_bib10","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.1210\/en.2012-1522","article-title":"Testosterone and 17beta-estradiol induce glandular prostatic growth, bladder outlet obstruction, and voiding dysfunction in male mice","volume":"153","author":"Nicholson","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajpath.2017.07.014_bib11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.diff.2013.02.006","article-title":"Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment","volume":"85","author":"Nicholson","year":"2013","journal-title":"Differentiation"},{"key":"10.1016\/j.ajpath.2017.07.014_bib12","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.juro.2014.08.093","article-title":"Estrogen receptor-alpha is a key mediator and therapeutic target for bladder complications of benign prostatic hyperplasia","volume":"193","author":"Nicholson","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.ajpath.2017.07.014_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5152\/dir.2015.15361","article-title":"Magnetic resonance imaging of benign prostatic hyperplasia","volume":"22","author":"Guneyli","year":"2016","journal-title":"Diagn Interv Radiol"},{"key":"10.1016\/j.ajpath.2017.07.014_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s11548-015-1287-x","article-title":"Correlation of magnetic resonance imaging with digital histopathology in prostate","volume":"11","author":"Kwak","year":"2016","journal-title":"Int J Comput Assist Radiol Surg"},{"key":"10.1016\/j.ajpath.2017.07.014_bib15","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.juro.2011.07.013","article-title":"Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds","volume":"186","author":"Turkbey","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.ajpath.2017.07.014_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0033-8389(05)70148-2","article-title":"Benign prostatic hyperplasia: clinical overview and value of diagnostic imaging","volume":"38","author":"Grossfeld","year":"2000","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.ajpath.2017.07.014_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1148\/radiology.172.1.2472644","article-title":"Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings","volume":"172","author":"Schiebler","year":"1989","journal-title":"Radiology"},{"key":"10.1016\/j.ajpath.2017.07.014_bib18","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00330-016-4479-z","article-title":"Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate","volume":"27","author":"De Visschere","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ajpath.2017.07.014_bib19","doi-asserted-by":"crossref","first-page":"e53701","DOI":"10.1371\/journal.pone.0053701","article-title":"Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer","volume":"8","author":"Kregel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2017.07.014_bib20","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/pros.22677","article-title":"Of mice and men-warning: intact versus castrated adult male mice as xenograft hosts are equivalent to hypogonadal versus abiraterone treated aging human males, respectively","volume":"73","author":"Sedelaar","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.ajpath.2017.07.014_bib21","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/nbm.3348","article-title":"MRI accurately identifies early murine mammary cancers and reliably differentiates between in situ and invasive cancer: correlation of MRI with histology","volume":"28","author":"Mustafi","year":"2015","journal-title":"NMR Biomed"},{"key":"10.1016\/j.ajpath.2017.07.014_bib22","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1158\/0008-5472.CAN-03-0946","article-title":"Prostate pathology of genetically engineered mice: definitions and classification: the consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee","volume":"64","author":"Shappell","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2017.07.014_bib23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0094-0143(21)00960-5","article-title":"Clinical and experimental studies of benign prostatic hyperplasia","volume":"17","author":"Coffey","year":"1990","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.ajpath.2017.07.014_bib24","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI108353","article-title":"The induction of prostatic hypertrophy in the dog with androstanediol","volume":"57","author":"Walsh","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2017.07.014_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0090-4295(00)00938-9","article-title":"Similarities of prostate and breast cancer: evolution, diet, and estrogens","volume":"57","author":"Coffey","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.ajpath.2017.07.014_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/pros.2990260302","article-title":"Microvascularity in benign prostatic hyperplasia","volume":"26","author":"Deering","year":"1995","journal-title":"Prostate"},{"key":"10.1016\/j.ajpath.2017.07.014_bib27","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0022-5347(01)64702-5","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia as a function of age, volume and ultrasonic appearance of the prostate","volume":"157","author":"Kojima","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.ajpath.2017.07.014_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1464-410x.2000.00322.x","article-title":"Microvessel density in prostatic hyperplasia","volume":"85","author":"Foley","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.ajpath.2017.07.014_bib29","first-page":"118","article-title":"[Histological characteristics of the prostate in men who receive re-TURP for benign prostatic hyperplasia and their clinical significance]","volume":"16","author":"Sun","year":"2010","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1016\/j.ajpath.2017.07.014_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00270-009-9727-z","article-title":"Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients","volume":"33","author":"Carnevale","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ajpath.2017.07.014_bib31","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0022-5347(17)36446-7","article-title":"Treatment of prostatic bleeding: suppression of angiogenesis by androgen deprivation","volume":"149","author":"Marshall","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.ajpath.2017.07.014_bib32","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1464-410X.2005.05849.x","article-title":"Randomized, placebo-controlled trial showing that finasteride reduces prostatic vascularity rapidly within 2 weeks","volume":"96","author":"Donohue","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.ajpath.2017.07.014_bib33","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.urology.2006.03.038","article-title":"Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia","volume":"68","author":"Lekas","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.ajpath.2017.07.014_bib34","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/pros.20444","article-title":"Finasteride targets prostate vascularity by inducing apoptosis and inhibiting cell adhesion of benign and malignant prostate cells","volume":"66","author":"Sutton","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.ajpath.2017.07.014_bib35","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0022-5347(05)65188-9","article-title":"Decreased suburethral prostatic microvessel density in finasteride treated prostates: a possible mechanism for reduced bleeding in benign prostatic hyperplasia","volume":"167","author":"Hochberg","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.ajpath.2017.07.014_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0022-5347(05)64025-6","article-title":"The effect of finasteride on the expression of vascular endothelial growth factor and microvessel density: a possible mechanism for decreased prostatic bleeding in treated patients","volume":"169","author":"Pareek","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.ajpath.2017.07.014_bib37","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00508-008-0986-5","article-title":"[Pathophysiology and therapy of benign prostatic hyperplasia]","volume":"120","author":"Sampson","year":"2008","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.ajpath.2017.07.014_bib38","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrurol.2016.168","article-title":"Inflammatory mediators in the development and progression of benign prostatic hyperplasia","volume":"13","author":"De Nunzio","year":"2016","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.ajpath.2017.07.014_bib39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/pros.10084","article-title":"Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation","volume":"52","author":"Kramer","year":"2002","journal-title":"Prostate"},{"key":"10.1016\/j.ajpath.2017.07.014_bib40","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2008.12.004","article-title":"Oestrogens and prostate cancer: novel concepts about an old issue","volume":"55","author":"Briganti","year":"2009","journal-title":"Eur Urol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944017304820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944017304820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T10:57:51Z","timestamp":1659351471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944017304820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0002944017304820"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2017.07.014","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Magnetic Resonance Imaging and Molecular Characterization of a Hormone-Mediated Murine Model of Prostate Enlargement and Bladder Outlet Obstruction","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2017.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}